Phillips 66 beats by $0.48: Reports Q2 (Jun) earnings of $2.23 per share, excluding non-recurring items, $0.48 better than the Capital IQ Consensus Estimate of $1.75. R&M second-quarter earnings were $1,184 mln, compared with $774 mln a year ago.Enterprise Products: income up, revenues down:
Enterprise Products beats by $0.10, misses on revs: Reports Q2 (Jun) earnings of $0.64 per share, $0.10 better than the Capital IQ Consensus Estimate of $0.54; revenues fell 12.7% year/year to $9.79 bln vs the $11.72 bln consensus.MRO reports solid 2Q12 profits
56 cents per share, for the three months ended June 30. That compares with $1.39 per share, a year ago.ONEOK earnings increase
QEP: after four straight earnings increases, this time they decrease;
*****************
- 21182, drl, KOG, Smokey Kenny 16-20-17-2H3, Pembroke,
- 21209, 1,458, WLL, Tifft 21-18H, Pleasant Hill, 2/12; cum 36K 6/12;
- 21659, 1,452, Oasis, Storseth 5603 12-27H, Bull Butte, t3/12; cum 21K 6/12;
- 21938, 733, Sinclair State 2-36H, Robinson Lake, t4/12; cum 19K 6/12;
- 22030, 422, CLR, Otter 1-11H, Viking; t5/12; cum 23K 6/12;
- Operators: CLR (4), OXY USA, BEXP, Triangle, XTO
- Fields: Hungry Man Butte (Billings), Alger (Mountrail), Rawson (McKenzie), Camp (McKenzie), Sand Creek (McKenzie)
*****************
Energy links at Independent Stock Analysis. The milestones in oil production worldwide are simply astounding.
*****************f
Another great energy primer from RBN Energy: this time on the diesel boom.
http://www.usatoday.com/money/industries/energy/story/2012-07-11/natural-gas-finds-lower-energy-costs/56157080/1
ReplyDeleteThe Billion number.
The carry word.
Anon 1
You are correct about the significance of the "billion" number. Years ago, I was told that in Big Pharma, a drug had to have the potential to generate a billion dollars in annual sales to be considered worth marketing.
Delete